Organization | Government of Finland

Government of Finland Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4

Founded: Helsinki Finland (1920)

Organization Overview

First Clinical Trial

1994

NCT00966264

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Academy of Finland | Academy of Finland (Risto O Roine) | Business Finland (National Innovation Agency) | Central Finland Hospital District | Centre for Military Medicine, Helsinki, Finland | City of Espoo | City of Tampere (Finland), Social and Health Services, Dental treatment | City of Turku | City of Vantaa | Department of Oncology, Vaasa Central Hospital, Vaasa, Finland | Dept of Otolaryngology, Kokkola Central Hospital, Finland | Heart Center, Pirkanmaa Hospitla District | Herttoniemi Hospital | Joint Authority for Päijät-Häme Social and Health Care | Kokkola Central Hospital, Finland | Kymeenlaakso Central Hospital | Kymenlaakso Central Hospital Kotka Finland | Lapland Central Hospital | Lapland Central Hospital Rovaniemi Finland | Laplnd Central Hospital Rovaniemi Finland | National Institute for Health and Welfare, Finland | National Istitute For Health and Welfare, Finland | North Carelia Central Hospital | North Karelia Central Hospital | Päijänne Tavastia Central Hospital | Pirkanmaa District Hospital | Pirkanmaa District Hospital, Department of Emergency Medicine | Pirkanmaa Hospital District, Tampere, Finland | Research Department, Centre for Military Medicine, Helsinki, Finland | Satakunta Central Hospital | Social services and Healthcare, City of Helsinki, Finland | South Karelia central hospital | The Laboratory and Pharmacy Public Utility of the Pirkanmaa Hospital District | Vaasa Central Hospital | Vaasa Central Hospital, Vaasa, Finland

Active Ingredients

Drugs in Phase 4 Trials (39)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

acamprosate (campral) (1 trial)

acetylsalicylic acid (aspirin) (2 trials)

aminolevulinic acid (levulan) (4 trials)

amiodarone (cordarone) (1 trial)

amoxicillin (1 trial)

azithromycin (zithromax) (2 trials)

calcium (1 trial)

clavulanate (Augmentin) (2 trials)

collagenase clostridium histolyticum (xiaflex) (1 trial)

cow milk (1 trial)

dalteparin (fragmin) (1 trial)

dexmedetomidine (precedex) (1 trial)

disulfiram (antabuse) (1 trial)

enoxaparin (lovenox) (1 trial)

escitalopram (lexapro) (2 trials)

ferrous sulfate (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

infliximab (remicade) (1 trial)

ketamine (ketalar) (1 trial)

levosimendan (1 trial)

memantine (namenda) (1 trial)

metformin (glucophage) (1 trial)

methyl aminolevulinate (metvixia) (4 trials)

metoprolol (lopressor) (1 trial)

naltrexone (revia) (4 trials)

nicotine (nicorette) (1 trial)

prednisone (meticorten) (2 trials)

procaine benzylpenicillin (novocaine) (2 trials)

propofol (diprivan) (1 trial)

ropivacaine (naropin) (1 trial)

sulfasalazine (azulfidine) (2 trials)

tafluprost (zioptan) (1 trial)

tinzaparin (Innohep) (1 trial)

vancomycin (Vancocin) (1 trial)

varenicline (chantix) (1 trial)

vitamin d3 (6 trials)

warfarin (coumadin) (1 trial)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 3 Trials (15)

atorvastatin (lipitor) (1 trial)

autologous adipose-derived mesenchymal stem cells (1 trial)

famotidine (pepcid) (1 trial)

lactobacillus delbrueckii (1 trial)

letrozole (femara) (1 trial)

live attenuated influenza virus vaccine (Flumist) (1 trial)

norgestrel (Ovral) (1 trial)

pneumococcal 7-valent conjugate vaccine (Prevnar) (1 trial)

pyrimethamine (daraprim) (1 trial)

soybean (1 trial)

sulfadoxine (1 trial)

testosterone (delatestryl) (1 trial)

toremifene (fareston) (2 trials)

trifolium pratense (1 trial)

Drugs in Phase 2 Trials (11)

anakinra (Kineret) (1 trial)

azathioprine (imuran) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

hexyl 5-aminolevulinate (Cysview) (2 trials)

Lactobacillus acidophilus (1 trial)

leflunomide (arava) (1 trial)

naloxone (narcan) (2 trials)

oxygen (2 trials)

sargramostim (leukine) (1 trial)

xenon-129 (Xenoview) (1 trial)

xenon xe-133 (1 trial)

Drugs in Phase 1 Trials (5)

allogeneic adipose derived mesenchymal stem cell (1 trial)

gip (1-42) (1 trial)

liraglutide (victoza) (1 trial)

mesalamine (rowasa) (1 trial)

simvastatin (zocor) (1 trial)

Drugs in Other Trials (13)

autologous microbiome (1 trial)

diclofenac (voltaren) (1 trial)

ertapenem (invanz) (1 trial)

galactooligosaccharide (1 trial)

human fecal microbiota (Reybota) (6 trials)

inulin (1 trial)

lactobacillus rhamnosus (1 trial)

moxifloxacin (avelox) (1 trial)

nicotinamide (1 trial)

parecoxib (1 trial)

platelet-rich plasma (1 trial)

valdecoxib (Bextra) (1 trial)

xylitol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alcoholism (Phase 4)

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 2)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 4)

Brain Injuries (Phase 2)

Brain Ischemia (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Communicable Diseases (Phase 4)

Consciousness Disorders (Phase 4)

Contracture (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 1)

Digestive System Diseases (Phase 3)

Dupuytren Contracture (Phase 4)

Eczema (Phase 4)

Embolism (Phase 4)

Fractures, Bone (Phase 4)

Gambling (Phase 4)

Gastrointestinal Diseases (Phase 3)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Growth Disorders (Phase 3)

Heart Arrest (Phase 2)

Heart Valve Diseases (Phase 4)

Hemorrhage (Phase 4)

Hutchinson's Melanotic Freckle (Phase 4)

Hypertension (Phase 4)

Hypothermia (Phase 2)

Infections (Phase 4)

Insulin Resistance (Phase 4)

Irritable Bowel Syndrome (Phase 2)

Ischemia (Phase 2)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Lentigo (Phase 4)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)

Liver Failure (Phase 1)

Malaria (Phase 3)

Malnutrition (Phase 3)

Mastodynia (Phase 3)

Menorrhagia (Phase 3)

Multiple Myeloma (Phase 2)

Neoplasms, Basal Cell (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Obesity (Phase 1)

Ocular Hypertension (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 4)

Osteoporosis (Phase 4)

Otitis (Phase 4)

Otitis Media (Phase 4)

Pain, Postoperative (Phase 4)

Pneumococcal Infections (Phase 3)

Pregnancy in Diabetics (Phase 4)

Premature Birth (Phase 3)

Prostatic Neoplasms (Phase 3)

Renal Insufficiency (Phase 1)

Respiratory Insufficiency (Phase 1)

Respiratory Sounds (Phase 4)

Respiratory Tract Infections (Phase 4)

Schizophrenia (Phase 3)

Sexually Transmitted Diseases (Phase 3)

Signs and Symptoms (Phase 4)

Sinusitis (Phase 4)

Still's Disease, Adult-Onset (Phase 2)

Stroke (Phase 1)

Thrombosis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 72
# of Trial APIs: 83